Kerecis

Kerecis

Kerecis

Kerecis is a developer of patent-pending MariGen™, an omega3 fish-skin acellulardermal matrix transplantation technology.
Type
B2c
Founded
2009
Raised
$5M
Follow us
Alexa global traffic share
Latest funding Show all
$3,000,000
Debt financing - 2018
$2,000,000
Venture capital (Series A) - 2014
NSA Ventures
Team Size
10+
Employees
Location
Headquarters
$3,000,000 Debt financing
Northstack

Medical fish skin company Kerecis closes $3m convertible note